← All organizations

Barr Laboratories

For profit

Also known as: BAR Pharmaceuticals s.r.l. | BARR | Barr Laboratories | BARR LABS DIV TEVA | BARR LABS INC | Barr Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Dec 15, 2024

Acquired by Teva on Jan 6, 2009

Timeline

1970s

Jun 1, 1970
Barr Laboratories— Founded

1990s

Apr 4, 1997
glipizide— Marketing Organization

2000s

Jun 1, 2001
Duramed Research— Acquired
Dec 20, 2004
conjugated equine estrogens— NDA Secondary Org
Jan 1, 2006
Pliva— Acquired
Jan 6, 2009
Teva— Acquired By

Drugs by trial phase (18 distinct, 32 trials)

Phase 4 (4 own, 2 via acquisition)

Phase 3 (0 own, 8 via acquisition)

Phase 2 (0 own, 1 via acquisition)

dr-2001

Phase 1 (1 own, 2 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 8 total across the full acquisition tree)

Recent trials (4)

NCT06705998Lead sponsorPhase 1Dec 15, 2024
NCT05203367Lead sponsorPhase 1Nov 25, 2022
NCT00259610CollaboratorPhase 4May 1, 2004
NCT00005623Lead sponsorPhase 3Dec 1, 1999

Details

Founded: Montvale, NJ, US Jun 1, 1970
Last known activity: Dec 15, 2024